|
⚲
|
| Jones Hill Capital LP
✚
|
|
|---|---|
| CRD # | 339686 |
| SEC # | 801-135105 |
| CIK # | 0002102314 |
| AUM | $642.4 M (2026-05-06) |
| Employees | 8 (50% Investors, 0% Brokers) |
| Phone | 212-328-9320 |
| Address | 60 Charlton Street New York, NY 10013 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002102314 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| BioMarin Pharmaceutical Inc | 71.7 | ||
| Vertex Pharmaceuticals Inc / Ma | 48.5 | ||
| Vaxcyte Inc | 37.5 | ||
| Nuvalent Inc | 30.8 | ||
| Nile Therapeutics Inc | 27.6 | ||
| Bicara Therapeutics Inc | 25.1 | ||
| Biosante Pharmaceuticals Inc | 24.5 | ||
| Ultragenyx Pharmaceutical Inc | 24.4 | ||
| Imara Inc | 23.2 | ||
| Amylyx Pharmaceuticals Inc | 22.2 | ||
| Argenx SE | 19.0 | ||
| Fulcrum Therapeutics Inc | 13.6 | ||
| VIR Biotechnology Inc | 10.7 | ||
| Panacea Acquisition Corp | 10.2 | ||
| ARCA Biopharma Inc | 6.9 | ||
| Contineum Therapeutics Inc | 6.7 | ||
| Veradermics Inc | 6.4 | ||
| Tamandare Explorations Inc | 6.2 | ||
| Structure Therapeutics Inc | 4.8 | ||
| Entrada Therapeutics Inc | 4.7 | ||
| Pharvaris NV | 4.7 | ||
| Trevi Therapeutics Inc | 4.4 | ||
| Camp Nine Inc | 2.4 | ||
| Silence Therapeutics PLC | 1.6 | ||
| Arrivent Biopharma Inc | 1.1 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| HF | Jones Hill Capital Master Fund LP | [2025-12-05] | 0.0 | 230.3 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 642.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 642.4 |
| By Discretionary | ||
| Discretionary | 8 | 642.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 642.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 533.7 | |
| United States Persons | 108.7 | |
| Total | 8 | 642.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Christopher Meekins | 3 | 3 | ||
| Jones Hill Capital LP | 2 | 2 | ||
| Soren Gandrud | 2 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002102314] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Polar Capital America Corporation
✚
|
FL | 0.7 |
|
Rings Capital Management LLC
✚
|
IL | 0.7 |
|
OCO Capital Partners LP
✚
|
NY | 0.7 |
|
Guardian Point Capital LP
✚
|
VA | 0.6 |
|
DAFNA Capital Management LLC
✚
|
CA | 0.6 |
|
Karya Capital Management LLC
✚
|
NY | 0.6 |
|
Stanley Capital Management LLC
✚
|
TX | 0.6 |
|
Simcoe Capital Management LLC
✚
|
NY | 0.6 |
|
G2 Investment Partners Management LLC
✚
|
NY | 0.6 |
|
Solas Capital Management LLC
✚
|
CT | 0.6 |